Xcout Intel
TME PHARMA
TME Pharma is a clinical-stage biotechnology company that develops novel therapies targeting the tumor microenvironment to treat aggressive cancers such as glioblastoma and pancreatic cancer. Its proprietary technology neutralizes chemokines to break down tumor protection barriers, allowing combination treatments to achieve a greater therapeutic impact.
Subscribe to see TME PHARMA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
TME PHARMA at a glance
TME PHARMA is a biotech company headquartered in France. Xcout tracks 3 named people at TME PHARMA, including Bryan Jennings (Executive / Officer).
TME PHARMA leadership
- Bryan JenningsExecutive / Officer
- Diede Mink van den OudenSupervisory Board Member / Appointee
- Dirk EulbergSupervisory Board Member / Appointee
Get TME PHARMA's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on TME PHARMA in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access